MX2023002619A - Derivados nitrados de psilocibina y uso de los mismos para modular el receptor 5-ht2a y para tratar un trastorno psiquiatrico. - Google Patents
Derivados nitrados de psilocibina y uso de los mismos para modular el receptor 5-ht2a y para tratar un trastorno psiquiatrico.Info
- Publication number
- MX2023002619A MX2023002619A MX2023002619A MX2023002619A MX2023002619A MX 2023002619 A MX2023002619 A MX 2023002619A MX 2023002619 A MX2023002619 A MX 2023002619A MX 2023002619 A MX2023002619 A MX 2023002619A MX 2023002619 A MX2023002619 A MX 2023002619A
- Authority
- MX
- Mexico
- Prior art keywords
- sub
- nitrated
- psilocybin
- alkyl
- group
- Prior art date
Links
- 208000020016 psychiatric disease Diseases 0.000 title abstract 2
- QVDSEJDULKLHCG-UHFFFAOYSA-N psilocybin Chemical class C1=CC(OP(O)(O)=O)=C2C(CCN(C)C)=CNC2=C1 QVDSEJDULKLHCG-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- QKTAAWLCLHMUTJ-UHFFFAOYSA-N psilocybin Chemical class C1C=CC(OP(O)(O)=O)=C2C(CCN(C)C)=CN=C21 QKTAAWLCLHMUTJ-UHFFFAOYSA-N 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/01005—Arylamine N-acetyltransferase (2.3.1.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
- C12Y401/01028—Aromatic-L-amino-acid decarboxylase (4.1.1.28), i.e. tryptophane-decarboxylase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/01—Hydro-lyases (4.2.1)
- C12Y402/0102—Tryptophan synthase (4.2.1.20)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063073534P | 2020-09-02 | 2020-09-02 | |
| PCT/CA2021/051214 WO2022047583A1 (en) | 2020-09-02 | 2021-09-02 | Nitrated psilocybin derivatives and use thereof for modulating 5-ht2a receptor and for treating a psychiatric disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023002619A true MX2023002619A (es) | 2023-04-10 |
Family
ID=80492288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023002619A MX2023002619A (es) | 2020-09-02 | 2021-09-02 | Derivados nitrados de psilocibina y uso de los mismos para modular el receptor 5-ht2a y para tratar un trastorno psiquiatrico. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230040398A1 (https=) |
| EP (1) | EP4208446A4 (https=) |
| JP (1) | JP2023539390A (https=) |
| KR (1) | KR20230061473A (https=) |
| CN (1) | CN116782896A (https=) |
| AU (1) | AU2021336667A1 (https=) |
| CA (1) | CA3191095A1 (https=) |
| IL (1) | IL301028A (https=) |
| MX (1) | MX2023002619A (https=) |
| WO (1) | WO2022047583A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3152752A1 (en) | 2019-10-01 | 2021-04-08 | Thomas Henley | Genetic engineering of fungi to modulate tryptamine expression |
| KR20230157342A (ko) | 2021-02-12 | 2023-11-16 | 인베릭 바이오사이언시스 캐나다 인크. | 다중 치환기 실로시빈 유도체 및 사용 방법 |
| CN118984868A (zh) | 2021-12-31 | 2024-11-19 | 恩派瑞安神经科学公司 | 用于产生精神药物生物碱的遗传修饰的生物体 |
| WO2023168023A1 (en) | 2022-03-04 | 2023-09-07 | Reset Pharmaceuticals, Inc. | Co-crystals or salts comprising psilocin |
| WO2023173196A1 (en) | 2022-03-18 | 2023-09-21 | Enveric Biosciences Canada Inc. | C4-carboxylic acid-substituted tryptamine derivatives and methods of using |
| AU2023234202A1 (en) * | 2022-03-18 | 2024-11-07 | Enveric Biosciences Canada Inc. | Salts of c4-carboxylic acid- and c4-carbonothioate-substituted tryptamine derivatives and methods of using |
| AU2023382178A1 (en) * | 2022-11-18 | 2025-06-05 | Enveric Biosciences Canada Inc. | Substituted n-propylamine fused heterocyclic mescaline derivatives |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4425399A (en) * | 1998-06-08 | 1999-12-30 | Advanced Medicine, Inc. | Novel therapeutic agents that modulate 5-ht receptors |
| KR20030046395A (ko) * | 2000-07-28 | 2003-06-12 | 인스파이어 파마슈티컬스 인코퍼레이티드 | 인돌 유도체를 사용하여 안압을 감소시키는 방법 |
| ES2172415B2 (es) * | 2000-07-28 | 2003-11-16 | Univ Madrid Complutense | Tratamiento del glaucoma y la hipertension ocular por medio de un analogo de la melatonina. |
| DK1859798T3 (en) * | 2001-03-29 | 2016-03-21 | Lilly Co Eli | N- (2-arylethyl) -BENZYLAMINER as antagonists of 5-HT6 receptor |
| EP1747779A1 (en) * | 2005-07-28 | 2007-01-31 | Laboratorios Del Dr. Esteve, S.A. | Tetrahydro-b-carbolin-sulfonamide derivatives as 5-HT6 ligands |
| CN103601662B (zh) * | 2013-11-21 | 2016-04-06 | 深圳市药品检验所 | 一种褪黑素半抗原、褪黑素完全抗原及其制备方法和应用 |
| EP3119406B1 (en) * | 2014-03-18 | 2021-01-20 | Carmel-Haifa University Economic Corporation Ltd | Methods for improving cognitive function via modulation of quinone reductase 2 |
| US11078467B2 (en) * | 2016-10-26 | 2021-08-03 | University Of Florida Research Foundation, Incorporated | Highly active self-sufficient nitration biocatalysts |
| US11261157B2 (en) * | 2016-12-08 | 2022-03-01 | Novatarg, Inc. | Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy |
| US20200147038A1 (en) * | 2017-04-20 | 2020-05-14 | Eleusis Benefit Corporation, Pbc | Assessing and treating psychedelic-responsive subjects |
| US10640508B2 (en) * | 2017-10-13 | 2020-05-05 | Massachusetts Institute Of Technology | Diazene directed modular synthesis of compounds with quaternary carbon centers |
-
2021
- 2021-09-02 WO PCT/CA2021/051214 patent/WO2022047583A1/en not_active Ceased
- 2021-09-02 CA CA3191095A patent/CA3191095A1/en active Pending
- 2021-09-02 MX MX2023002619A patent/MX2023002619A/es unknown
- 2021-09-02 KR KR1020237011175A patent/KR20230061473A/ko not_active Withdrawn
- 2021-09-02 EP EP21863154.7A patent/EP4208446A4/en active Pending
- 2021-09-02 CN CN202180068083.6A patent/CN116782896A/zh active Pending
- 2021-09-02 AU AU2021336667A patent/AU2021336667A1/en not_active Abandoned
- 2021-09-02 IL IL301028A patent/IL301028A/en unknown
- 2021-09-02 JP JP2023537445A patent/JP2023539390A/ja active Pending
-
2022
- 2022-09-09 US US17/941,531 patent/US20230040398A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20230040398A1 (en) | 2023-02-09 |
| CN116782896A (zh) | 2023-09-19 |
| WO2022047583A1 (en) | 2022-03-10 |
| EP4208446A1 (en) | 2023-07-12 |
| IL301028A (en) | 2023-05-01 |
| AU2021336667A1 (en) | 2023-03-30 |
| EP4208446A4 (en) | 2024-10-30 |
| AU2021336667A8 (en) | 2023-04-13 |
| CA3191095A1 (en) | 2022-03-10 |
| JP2023539390A (ja) | 2023-09-13 |
| KR20230061473A (ko) | 2023-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023002619A (es) | Derivados nitrados de psilocibina y uso de los mismos para modular el receptor 5-ht2a y para tratar un trastorno psiquiatrico. | |
| RU94040390A (ru) | Производные виниленазаиндола, способ их получения, фармацевтическая композиция | |
| MX9800577A (es) | Derivados de 4,5-diaril oxazol. | |
| KR870006072A (ko) | 라파마이신 전구체의 제조방법 | |
| ATE14579T1 (de) | Pharmazeutische heterocyclische verbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen. | |
| ES8606876A1 (es) | Procedimiento para preparar difosfonatos | |
| NZ242243A (en) | 2-substituted adenine triphosphate derivatives and pharmaceutical compositions | |
| ES269967A1 (es) | Un procedimiento para la preparaciën de pirazolonas sustituidas | |
| BG104933A (en) | Water soluble azoles and broad-spectrum antifungals | |
| GB1291675A (en) | 0-(1,3,4-thiadiazol-2-yl)-imidazolidinone(2) derivatives, process for their production and their use as herbicidal agents | |
| NZ333705A (en) | Furan nitrone derivatives and medicaments thereof | |
| DE60027034D1 (de) | 1-substituierte-phenyl-1-(1h-imidazol-4-yl)alkohole, verfahren zu deren herstellung sowie deren verwendung | |
| WO2003022797A1 (en) | Carba-sugar amine derivatives and treatments for disorder of glycolipid metabolism containing the same as the active ingredient | |
| ES455741A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 1,3-bencenodimetanol. | |
| MY121785A (en) | Hydroxamic acid derivatives as inhibitors of the production of soluble cd23 | |
| NZ508852A (en) | 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use in treating CNS and circulation disorders | |
| ES8106725A1 (es) | Procedimiento de preparar derivados 1,2,4-oxadiazolin-5-oni-cos | |
| ES8200692A1 (es) | Procedimiento para la preparacion de nuevas cefalosporinas | |
| ES8201977A1 (es) | Procedimiento de preparacion de aminoalcoxipirazoles | |
| ES8801637A1 (es) | Un procedimiento para la preparacion de benzimidazoles. | |
| PT1189908E (pt) | Alcaloides de indolocarbazole de um actinomiceto marinho | |
| ES8106537A1 (es) | Procedimiento de preparacion de nuevos fosfatos de n-(fenilosubstituido)-n-(alcoxicarbonilalcohil)-acetamidas | |
| ES8602756A1 (es) | Procedimiento para preparar nuevos derivados de 2-(1-imida- zolil)-etanol | |
| IL110644A0 (en) | Azoxycyanobenzene derivatives | |
| ES8302695A1 (es) | Procedimiento para la obtencion de nuevos compuestos de poliglicidilurazol n.substituidos. |